Speaker Profile

SVP & Global Head of Commercial, Kite Pharma

Biography
Warner Biddle joined Kite in 2020.Before joining Kite, Warner served as Vice President for the BreastGynecologic and Skin Cancer Franchises at Genentech. There he successfully led the crossfunctional strategy and launches for several commercial and pipeline products while driving significant portfolio growth.Prior to his oncology roles, Warner served as Vice President, Sales and Marketing for Ophthalmology at Genentech and also held various global leadership roles in Europe and Canada across multiple therapeutic disease areas at Novartis and GlaxoSmithKline.Warner received a bachelors degree in commerce with Honors from the University of Saskatchewan.


 Session Abstract – PMWC 2023 Silicon Valley

Track 1 - January 26 9.00 A.M.-4.30 P.M.


Track Chair: Sharon Benzeno, Adaptive Biotechnologies

  • PMWC 2023 Luminary Award Ceremony
    Honoree: Bruce Levine, University of Pennsylvania
  • Advance and Optimize Cell Therapies in Oncology (PANEL)
    Chair: Sharon Benzeno, Adaptive Biotechnologies
    - Ira Mellman, Genenetch
    - Mark Selby, Walking Fish Therapeutics
    - Sneha Ramakrishna, Stanford
    - Loïc VINCENT, Affini-T Therapeutics
    - Nick Haining, Arsenal
    - Warner Biddle, Kite
  • Pioneering Cell Therapies in the Treatment of Autoimmune Disorders (PANEL)
    Chair: Carl June, UPenn
    - Lenny Dragone, Sonoma
    - James Chung, Kyverna
    - David Chang, Cabaletta
    - Cristina Musselli, Abata Therapeutics
  • Innovations in Cell Therapy Manufacturing (PANEL)
    Chair: Bruce Levine, University of Pennsylvania
    - Chris Holt, BMS
    - Heidi Hagen, Sonoma Bio
    - Rahul Singhvi, Resilience
    - Snehal Patel, Sana Biotechnology
  • Patentability of Immunotherapies - Latest Developments
    - Janet Xiao, Morrison & Foerster LLP
  • Investing in Gene-Modified Cell Therapies
    Chair: Karen Tkach Tuzman, BioCentury Inc.
    - Robert Lin, UPMC
    - Yvonne Yamanaka, venBio
    - Abraham Bassan, Samsara Capital
    - Brian Daniels, 5am Ventures
  • Leveraging Data Sets to Inform Future Drug Discovery and Development (PANEL)
    Chair: Jason Coloma, Maze Therapeutics
    - Peter DiLaura, Sonoma Bio
    - Nick Haining, Arsenal
    - Kwame Okrah, Parker Institute
    - Dan Kirouac, Notch Therapeutics